Maribavir Impurity 2
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

193526-90-8Maribavir Impurity 2

● In Stock

Catalogue No.:VE0028045
CAS No.:193526-90-8
Mol. Formula:C16H20Cl3N3O3
Mol. Weight:408.71 g/mol

Additional information on CAS 193526-90-8

Parent drug

Maribavir

IUPAC Name

(2S,3S,4R,5R)-2-(2-(Tert-butylamino)-5,6-dichloro-1H-benzo[d]imidazol-1-yl)-5-(chloromethyl)tetrahydrofuran-3,4-diol

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

CC(C)(NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@@H](O[C@H]3CCl)[C@@H](O)[C@H]3O)C

InChI

InChI=1S/C16H20Cl3N3O3/c1-16(2,3)21-15-20-9-4-7(18)8(19)5-10(9)22(15)14-13(24)12(23)11(6-17)25-14/h4-5,11-14,23-24H,6H2,1-3H3,(H,20,21)/t11-,12-,13-,14-/m0/s1

Description

Maribavir Impurity 2 (CAS 193526-90-8) is a process-related or degradation impurity encountered during synthesis and stability assessment of the maribavir API, requiring precise identification and quantification by HPLC with UV detection, LC-MS and NMR for reliable impurity profiling and specification setting. Control strategies should focus on minimizing formation through optimized reaction conditions and purification steps, while qualification and toxicological risk assessment in line with ICH Q3A and ICH M7 support safety evaluation and specification limits. Availability of certified reference material and validated analytical methods ensures robust batch release and regulatory compliance.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url